Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex

  • Lia Baki
    Department of Psychiatry and Fishberg Research Center for Neurobiology and Department of Biochemistry and Molecular Biology, Mount Sinai School of Medicine, New York, NY 10029; Department of Neuroscience, University of California at San Diego, La Jolla, CA 92093; and Department of Biochemistry, Faculty of Medicine, Kagoshima University, Kagoshima 890-8520, Japan
  • Philippe Marambaud
    Department of Psychiatry and Fishberg Research Center for Neurobiology and Department of Biochemistry and Molecular Biology, Mount Sinai School of Medicine, New York, NY 10029; Department of Neuroscience, University of California at San Diego, La Jolla, CA 92093; and Department of Biochemistry, Faculty of Medicine, Kagoshima University, Kagoshima 890-8520, Japan
  • Spiros Efthimiopoulos
    Department of Psychiatry and Fishberg Research Center for Neurobiology and Department of Biochemistry and Molecular Biology, Mount Sinai School of Medicine, New York, NY 10029; Department of Neuroscience, University of California at San Diego, La Jolla, CA 92093; and Department of Biochemistry, Faculty of Medicine, Kagoshima University, Kagoshima 890-8520, Japan
  • Anastasios Georgakopoulos
    Department of Psychiatry and Fishberg Research Center for Neurobiology and Department of Biochemistry and Molecular Biology, Mount Sinai School of Medicine, New York, NY 10029; Department of Neuroscience, University of California at San Diego, La Jolla, CA 92093; and Department of Biochemistry, Faculty of Medicine, Kagoshima University, Kagoshima 890-8520, Japan
  • Paul Wen
    Department of Psychiatry and Fishberg Research Center for Neurobiology and Department of Biochemistry and Molecular Biology, Mount Sinai School of Medicine, New York, NY 10029; Department of Neuroscience, University of California at San Diego, La Jolla, CA 92093; and Department of Biochemistry, Faculty of Medicine, Kagoshima University, Kagoshima 890-8520, Japan
  • Wen Cui
    Department of Psychiatry and Fishberg Research Center for Neurobiology and Department of Biochemistry and Molecular Biology, Mount Sinai School of Medicine, New York, NY 10029; Department of Neuroscience, University of California at San Diego, La Jolla, CA 92093; and Department of Biochemistry, Faculty of Medicine, Kagoshima University, Kagoshima 890-8520, Japan
  • Junichi Shioi
    Department of Psychiatry and Fishberg Research Center for Neurobiology and Department of Biochemistry and Molecular Biology, Mount Sinai School of Medicine, New York, NY 10029; Department of Neuroscience, University of California at San Diego, La Jolla, CA 92093; and Department of Biochemistry, Faculty of Medicine, Kagoshima University, Kagoshima 890-8520, Japan
  • Eduard Koo
    Department of Psychiatry and Fishberg Research Center for Neurobiology and Department of Biochemistry and Molecular Biology, Mount Sinai School of Medicine, New York, NY 10029; Department of Neuroscience, University of California at San Diego, La Jolla, CA 92093; and Department of Biochemistry, Faculty of Medicine, Kagoshima University, Kagoshima 890-8520, Japan
  • Masayuki Ozawa
    Department of Psychiatry and Fishberg Research Center for Neurobiology and Department of Biochemistry and Molecular Biology, Mount Sinai School of Medicine, New York, NY 10029; Department of Neuroscience, University of California at San Diego, La Jolla, CA 92093; and Department of Biochemistry, Faculty of Medicine, Kagoshima University, Kagoshima 890-8520, Japan
  • Victor L. Friedrich
    Department of Psychiatry and Fishberg Research Center for Neurobiology and Department of Biochemistry and Molecular Biology, Mount Sinai School of Medicine, New York, NY 10029; Department of Neuroscience, University of California at San Diego, La Jolla, CA 92093; and Department of Biochemistry, Faculty of Medicine, Kagoshima University, Kagoshima 890-8520, Japan
  • Nikolaos K. Robakis
    Department of Psychiatry and Fishberg Research Center for Neurobiology and Department of Biochemistry and Molecular Biology, Mount Sinai School of Medicine, New York, NY 10029; Department of Neuroscience, University of California at San Diego, La Jolla, CA 92093; and Department of Biochemistry, Faculty of Medicine, Kagoshima University, Kagoshima 890-8520, Japan

書誌事項

公開日
2001-02-27
DOI
  • 10.1073/pnas.041603398
公開者
Proceedings of the National Academy of Sciences

この論文をさがす

説明

<jats:p> Here we show that presenilin-1 (PS1), a protein involved in Alzheimer's disease, binds directly to epithelial cadherin (E-cadherin). This binding is mediated by the large cytoplasmic loop of PS1 and requires the membrane-proximal cytoplasmic sequence 604–615 of mature E-cadherin. This sequence is also required for E-cadherin binding of protein p120, a known regulator of cadherin-mediated cell adhesion. Using wild-type and PS1 knockout cells, we found that increasing PS1 levels suppresses p120/E-cadherin binding, and increasing p120 levels suppresses PS1/E-cadherin binding. Thus PS1 and p120 bind to and mutually compete for cellular E-cadherin. Furthermore, PS1 stimulates E-cadherin binding to β- and γ-catenin, promotes cytoskeletal association of the cadherin/catenin complexes, and increases Ca <jats:sup>2+</jats:sup> -dependent cell–cell aggregation. Remarkably, PS1 familial Alzheimer disease mutant ΔE9 increased neither the levels of cadherin/catenin complexes nor cell aggregation, suggesting that this familial Alzheimer disease mutation interferes with cadherin-based cell–cell adhesion. These data identify PS1 as an E-cadherin-binding protein and a regulator of E-cadherin function <jats:italic>in vivo</jats:italic> . </jats:p>

収録刊行物

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ